DYRK2 and chronic myelogenous leukemia, BCR-ABL1 positive: KLF4 inhibits DYRK2 gene expression by binding to the endogenous DYRK2 promoter and plays a role in maintaining c-Myc expression in CML stem/progenitor cells [12].